Salesforce (CRM) (RBS) (REGN) (SXCI) (BYI) (CI) Upgraded

Salesforce.com (NYSE: CRM), Royal Bank of Scotland (NYSE: RBS), Regeneron Pharma (NASDAQ: REGN), SXC Health Solutions (NASDAQ: SXCI), Bally Technologies Inc. (NYSE: BYI) and CIGNA Co. (NYSE: CI) were upgraded by analysts.

Salesforce.com (CRM) was upgraded by Raymond James (NYSE:RJF) from a “Market Perform” rating to an “Outperform” rating.

Royal Bank of Scotland (RBS) was upgraded by WestLB to a “Buy” rating.

Regeneron Pharma (REGN) was upgraded by Bank of America (NYSE:BAC)from an “Underperform” rating to a “Neutral” rating. They have a price target of $64.00 on the company.

SXC Health Solutions (SXCI) was upgraded by Cowen from a “Neutral” rating to an “Outperform” rating.

Bally Technologies Inc. (BYI) was upgraded by Deutsche Bank (NYSE:DB) from a “Hold” rating to a “Buy” rating. They have a price target of $45.00 on the company.

CIGNA Co. (CI) was upgraded by Bank of America to a “Buy” rating. They have a price target of $57.00 on the company.